INmune Bio, Inc.
INMBNASDAQHealthcare● Active
$1.24
$-0.02(-1.59%)
Market Cap$32965720
P/E Ratio—
52W High$11.64
52W Low$1.09
INmune Bio, Inc.（INMB）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · INMB · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.05M | $0.01M | $0.15M | $0.37M | $0.18M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $0.05M | $0.01M | $0.15M | $0.37M | $0.18M |
| Gross Margin %(computed) | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $20.66M | $33.17M | $20.27M | $17.07M | $20.54M |
| G&A Expenses | $10.26M | $9.48M | $9.62M | $9.26M | $8.79M |
| Total Operating Expenses | $30.92M | $42.65M | $29.90M | $26.32M | $29.33M |
| Operating Income | ($30.87M) | ($42.63M) | ($29.74M) | ($25.95M) | ($29.15M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.85M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($45.93M) | ($42.08M) | ($30.01M) | ($27.30M) | ($30.34M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($45.93M) | ($42.08M) | ($30.01M) | ($27.30M) | ($30.34M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.86 | $-2.11 | $-1.67 | $-1.52 | $-1.88 |
| Wtd Avg Shares | 26.59M | 19.94M | 17.98M | 17.93M | 16.13M |
| EBITDA | ($30.79M) | ($42.08M) | $0.00M | $0.00M | $0.00M |
| EBITDA Margin %(computed) | — | — | 0.00% | 0.00% | 0.00% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解INmune Bio, Inc.
关于INmune Bio, Inc.（INMB）损益表
INmune Bio, Inc.（INMB）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，INMB实现营收$0.00B，毛利润$0.00B（毛利率100.00%），净利润($0.05B)（净利率-91866.00%）。
常见问题
INMB · 4 问INmune Bio, Inc.（INMB）2025财年营收为$0.00B，同比up257.1%。
INMB revenueINMB salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09